Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B3 | P37058 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13009510 | 0.95 | ALDH1A1 (0.35) | HSD17B3ALDH1A1LMNACYP1A2CYP2C9 | |
| SCHEMBL13428172 | 0.95 | ALDH1A1 (0.36) | HSD17B3ALDH1A1LMNACYP1A2CYP2C9 | |
| SCHEMBL13428156 | 0.94 | ALDH1A1 (0.35) | HSD17B3ALDH1A1LMNACYP1A2CYP2C9 | |
| SCHEMBL13428214 | 0.94 | ALDH1A1 (0.35) | HSD17B3ALDH1A1LMNACYP1A2CYP2C9 | |
| SCHEMBL13427093 | 0.94 | PDK2 (0.32) | PDK2 | |
| SCHEMBL13008413 | 0.94 | ALDH1A1 (0.37) | ALDH1A1LMNACYP1A2CYP2C9HPGD | |
| SCHEMBL13008866 | 0.94 | ALDH1A1 (0.37) | ALDH1A1LMNACYP1A2CYP2C9HPGD | |
| SCHEMBL13008434 | 0.94 | HSD17B3 (0.35) | HSD17B3PDK2 | |
| SCHEMBL13008840 | 0.93 | HSD17B3 (0.33) | HSD17B3PDK2 | |
| SCHEMBL13428137 | 0.93 | HSD17B3 (0.33) | HSD17B3PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100051106-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-03-04 | — | — | US | disclosed |
| US-20100051106-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100051106-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | RPL36, RPL39, RPL36A | HSD17B3 3787/4885ALDH1A1 1477/4885LMNA 4186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.